Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7286 p174
14 February 2004

This article
Reprint
Photocopy


News summary

Related websites
JAMA abstract (more)


Call for improved evidence base for complementary medicine in UK

Complementary and alternative medicine (CAM) in the UK is under-researched and access to it is unequal, suggest the authors of an article in the Journal of Medical Ethics.

Led by Edzard Ernst, professor of complementary medicine at the Peninsula Medical School, Exeter, the authors point out that around one in five people in the UK uses complementary medicine. However, most users pay privately for CAM, leading to unequal distribution of these therapies among the population.

The authors believe that widespread use of CAM, which in many cases is untested, may put patients at risk. They suggest that adequate research funds must be made available to rectify this. The authors acknowledge that many CAM therapies are underpinned by philosophies that challenge orthodox medical perspectives, but say that there are no reasons why rigorous research cannot be undertaken (published online as a PDF file (75K)).

Meanwhile, US researchers have also called for the standards of evidence-based medicine to be applied to CAM. They suggest that placebo-controlled trials of CAM treatments are ethically justified and that the arguments that such trials are not appropriate lack merit (JAMA 2004;291:599).


  * PDF files on PJ Online require Acrobat Reader 4 or later

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal